<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02983773</url>
  </required_header>
  <id_info>
    <org_study_id>1511001372</org_study_id>
    <secondary_id>R01AA024091</secondary_id>
    <nct_id>NCT02983773</nct_id>
  </id_info>
  <brief_title>Marijuana's Impact on Alcohol Motivation and Consumption</brief_title>
  <official_title>Marijuana's Impact on Alcohol Motivation and Consumption</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Brown University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This laboratory study will employ a repeated measures experimental design to examine the&#xD;
      effect of high (7.2% THC) and moderate (3% THC) dose of marijuana, relative to placebo, on&#xD;
      alcohol craving and on behavioral economic measure of alcohol demand after exposure to&#xD;
      alcohol cues, and on subsequent drinking in an alcohol choice task in which participants&#xD;
      choose either to drink or receive monetary reinforcement for drinks not consume. The study&#xD;
      will recruit 173 non-treatment seeking heavy episodic alcohol drinkers who smoke marijuana at&#xD;
      least twice weekly.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This laboratory study will employ a repeated measures experimental design to examine the&#xD;
      effect of high (7.2% THC) and moderate (3.0% THC) dose of marijuana, relative to placebo, on&#xD;
      alcohol craving and on behavioral economic measure of alcohol demand after exposure to&#xD;
      alcohol cues, and on subsequent drinking in an alcohol choice task in which participants&#xD;
      choose either to drink or receive monetary reinforcement for drinks not consumed. Moderators&#xD;
      of the marijuana's effects on alcohol-related dependent variables will be tested: DSM5&#xD;
      alcohol use disorder severity, affective vulnerability, trait impulsivity, and working memory&#xD;
      functioning. Several empirically-determined mechanisms that may explain why marijuana may&#xD;
      increase risk of alcohol relapse and help maintain heavy drinking will be tested as mediators&#xD;
      of marijuana's effects on alcohol. The study will recruit 173 non-treatment seeking heavy&#xD;
      episodic alcohol drinkers who smoke marijuana at least twice weekly to obtain the final&#xD;
      sample of 150 with complete data (15% of attrition). Participants will be tested at a&#xD;
      baseline session and during three experimental sessions. Investigators will collect blood&#xD;
      samples for analysis of cannabinoid plasma levels and to examine marijuana-induced changes in&#xD;
      hormones and other biomarkers potentially related to appetite, inflammation and stress.&#xD;
      Collection of these biomarkers would allow for a greater understanding about the mechanisms&#xD;
      whereby marijuana may acutely increase alcohol motivation and use. The findings will inform&#xD;
      researchers and clinicians about how marijuana acutely increases alcohol craving and&#xD;
      consumption. The strategy of this proposal is to use the most comprehensive controlled test&#xD;
      characterizing marijuana's putative effects on alcohol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 23, 2017</start_date>
  <completion_date type="Actual">July 21, 2021</completion_date>
  <primary_completion_date type="Actual">July 21, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in alcohol craving</measure>
    <time_frame>T1: pre-smoking (-45 minutes) and post smoking at 20 (T2), 55 (T3), and 70 (T4) minutes for a total of two hours during the experimental session</time_frame>
    <description>Alcohol Craving Questionnaire-Short Form-Revised (ACQ-SF-R)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in alcohol demand measured with Alcohol Purchase Task-State Version (APT-SV)</measure>
    <time_frame>T1: pre-smoking (-45 minutes) and post smoking at 55 (T2) and 70 (T3) minutes for a total of two hours during the experimental session</time_frame>
    <description>Alcohol demand curve is generated by estimating alcohol consumption (number of drinks) over the course of escalating prices.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of alcohol beverages consumed</measure>
    <time_frame>post-smoking during two-hour alcohol choice task during the experimental session</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">131</enrollment>
  <condition>Alcohol Drinking</condition>
  <condition>Marijuana</condition>
  <arm_group>
    <arm_group_label>High THC dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 marijuana cigarette (7.2% THC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low THC dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 marijuana cigarette (3.0% THC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo marijuana cigarette</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>THC 7.2%</intervention_name>
    <description>1 smoked marijuana cigarette with 7.2% THC</description>
    <arm_group_label>High THC dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>THC 3.0%</intervention_name>
    <description>1 smoked marijuana cigarette with 3.0% THC</description>
    <arm_group_label>Low THC dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1 smoked placebo marijuana cigarette</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 21 to 44&#xD;
&#xD;
          -  English-speaking&#xD;
&#xD;
          -  marijuana smoking in past month&#xD;
&#xD;
          -  report of current heavy episodic (binge) drinking&#xD;
&#xD;
          -  in good physical health and weighing &lt; 250 lbs&#xD;
&#xD;
          -  zero breath alcohol at each visit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of seizures&#xD;
&#xD;
          -  smoking &gt;20 tobacco cigarettes per day&#xD;
&#xD;
          -  positive pregnancy test&#xD;
&#xD;
          -  nursing&#xD;
&#xD;
          -  positive urine toxicology screen for drugs other than cannabis&#xD;
&#xD;
          -  interest to quit or receive treatment for marijuana or alcohol use&#xD;
&#xD;
          -  meeting criteria for a current affective disorder (depression, or mania, panic&#xD;
             disorder, and having psychotic symptoms as assessed by the SCID)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jane Metrik, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brown University</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 15, 2016</study_first_submitted>
  <study_first_submitted_qc>December 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2016</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brown University</investigator_affiliation>
    <investigator_full_name>Jane Metrik</investigator_full_name>
    <investigator_title>Associate Professor (research)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dronabinol</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 20, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT02983773/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

